San Diego-based Viking Therapeutics marked by itself as a significant competitor while in the weight loss drug marketplace in February following revealing promising facts from the mid-stage trial of experimental drug VK2735, which instructed it rivaled—and outperformed—Novo and Lilly drugs when provided to be a weekly injection As well as in Ma